Bone mineral density in children with relapsing nephrotic syndrome

Iranian Journal of Medical Sciences

Volumn 31, Issue 2, 2006, Pages 82-86

  Basiratnia, M ^a   Fallahzadeh, M H ^a   Derakhshan, A ^a   Hosseini Al Hashemi, G ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

BMD; Corticosteroid; Nephrotic syndrome; Osteoporosis

Indexed keywords

CYCLOSPORIN; STEROID;

ADULT; ARTICLE; BODY HEIGHT; BONE DENSITY; BONE MINERAL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR; HUMAN; LUMBAR SPINE; MALE; NEPHROTIC SYNDROME; OSTEOPOROSIS; RECURRENT DISEASE;

EID: 33744950109     PISSN: 02530716     EISSN: 17353688     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Niaudet P. Steroid-sensitive idiopathic nephrotic syndrome in children. Avner E, Harmon WE, Niaudet P. In Pediatric Nephrology. Philadelphia. 5thedition. Lippincott Williams & Wilkins; 2004. p. 543-56.
2. Grymonprez A, Proesmns W, Van Dyck M, et al. Vitamin D metabolites in childhood nephrotic syndrome. Paediatr Nephrol 1995; 9: 278-81.
3. Lukert BP, Raisz LG, Glucocorticoid-induced osteoporosis: Pathogenesis and management. Ann Intern Med 1990; 112: 352-64.
4. Lukert BP, Raisz LG. Glucocorticoid induced osteoporosis. Rheum Dis Clin North Am 1994; 20: 629-50.
5. Hahn TJ, Halstead LR, Teitelbaum SL, et al. Altered mineral metabolism in glucocorticoid induced osteopenia. Effect of 25-hydroxy Vitamin D administration. J Clin Invest 1979; 64: 655-65.
6. Polito C, LaManna A, Todisco N, et al. Bone mineral content in nephrotic children on long-term, alternate-day prednisone therapy. Clin Pediatr (Phila) 1995; 34: 234-6.
7. Adachi JD, Bensen WG, Bianchi F, et al. Vitamin D and calcium in the prevention of corticosteroid induced osteoporosis: three year follow up. J Rheumatol 1996; 23: 995-1000.
8. Lettgen B, Jeken C, Reiners C. Influence of steroid medication on bone mineral density in children with nephrotic syndrome. Pediatr Nephrol 1994; 8: 667-70.
9. Esbjorner E, Arvidsson B, Jones IL, et al. Bone mineral content and collagen metabolites in children receiving steroid treatment for nephrotic syndrome. Acta Paediatr 2001; 90: 1127-30.
10. Fujita T, Satomura A, Hidaka M, et al. Acute alteration in bone mineral density and biochemical markers for bone metabolism in nephrotic patients receiving high dose glucocorticoid and one-cycle etidronate therapy. Calcif Tissue Int 2000; 66: 195-9.
11. Sierra RI, Specker BL, Jimenez F, et al. Biochemical bone markers, bone mineral content and bone mineral density in rats with experimental nephrotic syndrome. Ren Fail 1997; 19: 409-24.
12. Takeda Y. Evaluation of bone mineral turns over in children with nephrotic syndrome. The implication of original disease and the effects of corticosteroids on bone metabolism. Nippon Jinzo Gakkai Shi 1993; 35: 705-13.
13. th edition.Lippincott Williams & Wilkins; 1999. p. 731-43.
14. Warner JT, Cowan FJ, Dunstan FD, et al. Measured and predicted bone mineral content in healthy boys and girls aged 6-18 years: adjustment for body size and puberty. Acta paediatr 1998; 87: 244-9.
15. Faulkner KG. Update on bone density measurement. Rheum Dis Clin North Am 2001; 27: 81-99.
16. Kano K. Hoshi M. Nishikura K. et al. Skeletal effects of short-term prednisolone therapy in children with steroid-responsive nephrotic syndrome. Clin Exp Nephrol 2001; 5: 40-3.
17. Morin D, Kotzki PO, Dalla Vale P, et al. Bone mineral density in children with steroid sensitive nephrotic syndrome. Pediatr Nephrol 1996; 10: C147A.
18. Leonard MB, Feldman HI, Shults J, et al. Long term, high dose glucocorticoids and bone mineral content in childhood glucocorticoid sensitive nephrotic syndrome. N Engl J Med 2004; 351: 868-75.
19. Ruegsegger P, Medici TC, Anliker M. Corticosteroid induced bone loss. A longitudinal study of alternate day therapy in patients with bronchial asthma using quantitative computed tomography. Eur J Clin Pharmacol 1983; 25: 615-20.
20. Chesney RW, Mazess RB, Rose P, et al. Effect of prednisone on growth and bone mineral content in childhood glomerular disease. Am J Dis Child 1978; 132: 768-72.
21. Cunnane G, Lane NE. Steroid induced osteoporosis in systemic lupus erythematosus. Rheum Dis Clin North Am 2000; 26: 311-29.
22. Dempster DW. Bone histomorphometry in glucocorticoid induced osteoporosis. J Bone Miner Res 1989; 4: 137-41.
23. Gulati S, Godbole M, Singh U, et al. Are children with idiopathic nephrotic syndrome at risk for metabolic bone disease? Am J Kidney Dis 2003; 41:1163-9.
24. Thiebaud D, Krieg MA, Gillard-Berguer D, et al. Cyclosporine induces high bone turnover and may contribute to bone loss after heart transplantation. Eur J Clin Invest 1996; 26: 549-55.
25. Durieux S, Mercadal L, Orcet P, et al. Bone mineral density and fracture prevalence in long term kidney graft recipients. Transplantation 2002; 74: 496-500.